Resurgent Financial Advisors LLC Raises Position in Oracle Co. (NYSE:ORCL)

Resurgent Financial Advisors LLC boosted its holdings in shares of Oracle Co. (NYSE:ORCL) by 117.9% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 5,318 shares of the enterprise software provider’s stock after buying an additional 2,877 shares during the quarter. Resurgent Financial Advisors LLC’s holdings in Oracle were worth $886,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Principal Financial Group Inc. raised its position in shares of Oracle by 5.3% in the 3rd quarter. Principal Financial Group Inc. now owns 2,416,362 shares of the enterprise software provider’s stock valued at $411,748,000 after purchasing an additional 121,874 shares during the last quarter. McClarren Financial Advisors Inc. raised its holdings in shares of Oracle by 201.7% in the fourth quarter. McClarren Financial Advisors Inc. now owns 1,599 shares of the enterprise software provider’s stock worth $266,000 after buying an additional 1,069 shares during the last quarter. RMR Wealth Builders lifted its stake in shares of Oracle by 383.4% during the fourth quarter. RMR Wealth Builders now owns 7,155 shares of the enterprise software provider’s stock worth $1,192,000 after buying an additional 5,675 shares during the period. Foundations Investment Advisors LLC grew its holdings in shares of Oracle by 24.8% during the fourth quarter. Foundations Investment Advisors LLC now owns 164,593 shares of the enterprise software provider’s stock valued at $27,428,000 after buying an additional 32,718 shares during the last quarter. Finally, Crews Bank & Trust acquired a new position in shares of Oracle in the 4th quarter valued at $1,800,000. 42.44% of the stock is currently owned by hedge funds and other institutional investors.

Oracle Stock Performance

NYSE:ORCL opened at $133.83 on Wednesday. The company has a debt-to-equity ratio of 5.65, a quick ratio of 0.81 and a current ratio of 0.81. The stock has a market capitalization of $374.33 billion, a PE ratio of 32.72, a P/E/G ratio of 3.46 and a beta of 1.22. Oracle Co. has a fifty-two week low of $112.78 and a fifty-two week high of $198.31. The company has a fifty day moving average of $153.73 and a two-hundred day moving average of $167.15.

Oracle (NYSE:ORCL) last released its quarterly earnings results on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing the consensus estimate of $1.49 by ($0.02). Oracle had a return on equity of 133.25% and a net margin of 21.16%. The company had revenue of $14.13 billion for the quarter, compared to analyst estimates of $14.40 billion. During the same quarter last year, the company earned $1.41 EPS. The firm’s revenue for the quarter was up 6.4% on a year-over-year basis. As a group, research analysts forecast that Oracle Co. will post 5 earnings per share for the current fiscal year.

Oracle Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Thursday, April 10th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.49%. The ex-dividend date is Thursday, April 10th. This is an increase from Oracle’s previous quarterly dividend of $0.40. Oracle’s dividend payout ratio (DPR) is 46.95%.

Analyst Ratings Changes

A number of brokerages have commented on ORCL. JMP Securities reaffirmed a “market outperform” rating and set a $205.00 price target on shares of Oracle in a research report on Wednesday, January 22nd. StockNews.com downgraded Oracle from a “buy” rating to a “hold” rating in a report on Wednesday, February 19th. Royal Bank of Canada set a $145.00 target price on Oracle and gave the company a “sector perform” rating in a research report on Tuesday, March 11th. Piper Sandler decreased their price objective on shares of Oracle from $210.00 to $190.00 and set an “overweight” rating for the company in a research note on Tuesday, March 11th. Finally, UBS Group reiterated a “market perform” rating on shares of Oracle in a research note on Tuesday, March 11th. Thirteen research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $177.12.

Insider Transactions at Oracle

In related news, Director Leon E. Panetta sold 5,000 shares of the business’s stock in a transaction dated Friday, April 11th. The shares were sold at an average price of $129.77, for a total transaction of $648,850.00. Following the transaction, the director now directly owns 58,090 shares in the company, valued at approximately $7,538,339.30. The trade was a 7.93 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Safra Catz sold 2,101,154 shares of the stock in a transaction dated Wednesday, January 22nd. The shares were sold at an average price of $185.35, for a total transaction of $389,448,893.90. Following the completion of the sale, the chief executive officer now owns 1,118,592 shares of the company’s stock, valued at approximately $207,331,027.20. The trade was a 65.26 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 2,453,328 shares of company stock valued at $454,439,851 over the last ninety days. Insiders own 42.20% of the company’s stock.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.